Correction to: Synthesis, antiviral potency, in vitro ADMET, and X-ray structure of potent CD4 mimics as entry inhibitors that target the Phe43 cavity of HIV-1 gp120 (Journal of Medicinal Chemistry (2017) 60 (3124-3153) DOI: 10.1021/acs.jmedchem.7b00179);Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120

Journal of Medicinal Chemistry

Volumn 60, Issue 7, 2017, Pages 3124-3153

  Curreli, Francesca ^a   Kwon, Young Do ^b   Belov, Dmitry S ^c   Ramesh, Ranjith R ^a   Kurkin, Alexander V ^c   Altieri, Andrea ^c   Kwong, Peter D ^b   Debnath, Asim K ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 CHLOROPHENYL) 2,2 DIHYDROXYETHANONE; 1 TERT BUTYL 2METHYL 5 (4CHLOROPHENYL) 3 METHYL 1H PYRROLE 1,2 CARBOXYLATE; 2 (4 CHLOROPHENYL) 5 (TRIFLUOROMETHYL) 1H IMIDAZOLE; 5 (4 CHLOROPHENYL) 1 METHYL 1H PYRROLE 2 CARBOXYLATE; 5 (4 CHLOROPHENYL) 1 METHYL 1H PYRROLE 2 CARBOXYLIC ACID; 5 (4 CHLOROPHENYL) 1H IMIDAZOLE 2 CARBOXYLIC ACID; 5 (4 CHLOROPHENYL) 4 METHOXY 1H PYRROLE 2 CARBOXYLIC ACID; 5 (4 CHLOROPHENYL) 4 METHYL 1H PYRROLE 2 CARBOXYLIC ACID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ETHYL 1 ACETYL 5 (4 CHLOROPHENYL) 4 METHYL 1H PYRROLE 2 CARBOXYLATE; ETHYL 5 (4 CHLOROPHENYL) 1H IMIDAZOLE 2 CARBOXYLATE; KETOCONAZOLE; METHYL 4 (2 CHLOROACETOXY) 5 (4 CHLOROPHENYL) 1H PYRROLE 2 CARBOXYLATE; METHYL 4 (2 CHLOROACETYL) 5 (4 CHLOROPHENYL) 1H PYRROLE 2 CARBOXYLATE; METHYL 5 (4 CHLOROPHENYL) 1H PYRROLE 2 CARBOXYLATE; METHYL 5 (4 CHLOROPHENYL) 3 METHYL 1H PYRROLE 2 CARBOXYLATE; METHYL 5 (4 CHLOROPHENYL) 4 HYDROXY 1H PYRROLE 2 CARBOXYLATE; METHYL 5 (4 CHLOROPHENYL) 4 METHOXY 1 METHYL 1H PYRROLE 2 CARBOXYLATE; METHYL 5 (4 CHLOROPHENYL) 4 METHOXY 1H PYRROLE 2 CARBOXYLATE; NBD 14088; NBD 14107; NBD 556; NEVIRAPINE; QUINIDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SODIUM 5 (4 CHLOROPHENYL) 3 METHYL 1H PYRROLE 2 CARBOXYLATE; SULFAPHENAZOLE; TRANYLCYPROMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS FUSION INHIBITOR; BIOMIMETIC MATERIAL; CD4 ANTIGEN; GLYCOPROTEIN GP 120; NBD-11021; PYRROLE DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CACO-2 CELL LINE; CHO CELL LINE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TOXICITY; FEMALE; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; LIVER MICROSOME; NONHUMAN; STRUCTURE ACTIVITY RELATION; CELL LINE; CHEMISTRY; DRUG EFFECTS; HIV INFECTIONS; METABOLISM; MOLECULAR DOCKING; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; VIROLOGY; VIRUS ENTRY; X RAY CRYSTALLOGRAPHY;

ANTI-HIV AGENTS; ANTIGENS, CD4; BIOMIMETIC MATERIALS; CELL LINE; CRYSTALLOGRAPHY, X-RAY; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR DOCKING SIMULATION; MOLECULAR TARGETED THERAPY; PYRROLES; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES; VIRUS INTERNALIZATION;

EID: 85017525364     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.7b00690     Document Type: Erratum

References (74)

1. Caffrey, M. Hiv Envelope: Challenges and Opportunities for Development of Entry Inhibitors Trends Microbiol. 2011, 19, 191-197 10.1016/j.tim.2011.02.001
2. Didigu, C. A.; Doms, R. W. Novel Approaches to Inhibit Hiv Entry Viruses 2012, 4, 309-324 10.3390/v4020309
3. Yu, F.; Lu, L.; Du, L.; Zhu, X.; Debnath, A. K.; Jiang, S. Approaches for Identification of Hiv-1 Entry Inhibitors Targeting Gp41 Pocket Viruses 2013, 5, 127-149 10.3390/v5010127
4. Lu, L.; Yu, F.; Cai, L.; Debnath, A. K.; Jiang, S. Development of Small-Molecule Hiv Entry Inhibitors Specifically Targeting Gp120 or Gp41 Curr. Top. Med. Chem. 2016, 16, 1074-1090 10.2174/1568026615666150901114527
5. Duffalo, M. L.; James, C. W. Enfuvirtide: A Novel Agent for the Treatment of Hiv-1 Infection Ann. Pharmacother. 2003, 37, 1448-1456 10.1345/aph.1D143
6. Hardy, H.; Skolnik, P. R. Enfuvirtide, a New Fusion Inhibitor for Therapy of Human Immunodeficiency Virus Infection Pharmacotherapy 2004, 24, 198-211 10.1592/phco.24.2.198.33141
7. Dorr, P.; Westby, M.; Dobbs, S.; Griffin, P.; Irvine, B.; Macartney, M.; Mori, J.; Rickett, G.; Smith-Burchnell, C.; Napier, C.; Webster, R.; Armour, D.; Price, D.; Stammen, B.; Wood, A.; Perros, M. Maraviroc (Uk-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor Ccr5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity Antimicrob. Agents Chemother. 2005, 49, 4721-4732 10.1128/AAC.49.11.4721-4732.2005
8. Hunt, J. S.; Romanelli, F. Maraviroc, a Ccr5 Coreceptor Antagonist That Blocks Entry of Human Immunodeficiency Virus Type 1 Pharmacotherapy 2009, 29, 295-304 10.1592/phco.29.3.295
9. Meanwell, N. A.; Kadow, J. F. Maraviroc, a Chemokine Ccr5 Receptor Antagonist for the Treatment of Hiv Infection and Aids Curr. Opin. Invest. Drugs 2007, 8, 669-681
10. Nowicka-Sans, B.; Gong, Y. F.; McAuliffe, B.; Dicker, I.; Ho, H. T.; Zhou, N.; Eggers, B.; Lin, P. F.; Ray, N.; Wind-Rotolo, M.; Zhu, L.; Majumdar, A.; Stock, D.; Lataillade, M.; Hanna, G. J.; Matiskella, J. D.; Ueda, Y.; Wang, T.; Kadow, J. F.; Meanwell, N. A.; Krystal, M. In Vitro Antiviral Characteristics of Hiv-1 Attachment Inhibitor Bms-626529, the Active Component of the Prodrug Bms-663068 Antimicrob. Agents Chemother. 2012, 56, 3498-3507 10.1128/AAC.00426-12
11. Lalezari, J. P.; Latiff, G. H.; Brinson, C.; Echevarría, J.; Treviño-Pérez, S.; Bogner, J. R.; Thompson, M.; Fourie, J.; Sussmann Pena, O. A.; Mendo Urbina, F. C.; Martins, M.; Diaconescu, I. G.; Stock, D. A.; Joshi, S. R.; Hanna, G. J.; Lataillade, M. Safety and Efficacy of the Hiv-1 Attachment Inhibitor Prodrug Bms-663068 in Treatment-Experienced Individuals: 24 Week Results of Ai438011, a Phase 2b, Randomised Controlled Trial Lancet HIV 2 2015, 2, e427-e437 10.1016/S2352-3018(15)00177-0
12. Zhao, Q.; Ma, L.; Jiang, S.; Lu, H.; Liu, S.; He, Y.; Strick, N.; Neamati, N.; Debnath, A. K. Identification of N-Phenyl-N′-(2,2,6,6-Tetramethyl-Piperidin-4-Yl)-Oxalamides as a New Class of Hiv-1 Entry Inhibitors That Prevent Gp120 Binding to Cd4 Virology 2005, 339, 213-225 10.1016/j.virol.2005.06.008
13. Si, Z.; Madani, N.; Cox, J. M.; Chruma, J. J.; Klein, J. C.; Schon, A.; Phan, N.; Wang, L.; Biorn, A. C.; Cocklin, S.; Chaiken, I.; Freire, E.; Smith, A. B., III; Sodroski, J. G. Small-Molecule Inhibitors of Hiv-1 Entry Block Receptor-Induced Conformational Changes in the Viral Envelope Glycoproteins Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 5036-5041 10.1073/pnas.0307953101
14. Curreli, F.; Kwon, Y. D.; Zhang, H.; Scacalossi, D.; Belov, D. S.; Tikhonov, A. A.; Andreev, I. A.; Altieri, A.; Kurkin, A. V.; Kwong, P. D.; Debnath, A. K. Structure-Based Design of a Small Molecule Cd4-Antagonist with Broad Spectrum Anti-Hiv-1 Activity J. Med. Chem. 2015, 58, 6909-6927 10.1021/acs.jmedchem.5b00709
15. Curreli, F.; Kwon, Y. D.; Zhang, H.; Yang, Y.; Scacalossi, D.; Kwong, P. D.; Debnath, A. K. Binding Mode Characterization of Nbd Series Cd4-Mimetic Hiv-1 Entry Inhibitors by X-Ray Structure and Resistance Study Antimicrob. Agents Chemother. 2014, 58, 5478-5491 10.1128/AAC.03339-14
16. Curreli, F.; Choudhury, S.; Pyatkin, I.; Zagorodnikov, V. P.; Bulay, A. K.; Altieri, A.; Kwon, Y. D.; Kwong, P. D.; Debnath, A. K. Design, Synthesis and Antiviral Activity of Entry Inhibitors That Target the Cd4-Binding Site of Hiv-1 J. Med. Chem. 2012, 55, 4764-4775 10.1021/jm3002247
17. Curreli, F.; Belov, D. S.; Ramesh, R. R.; Patel, N.; Altieri, A.; Kurkin, A. V.; Debnath, A. K. Design, Synthesis and Evaluation of Small Molecule Cd4-Mimics as Entry Inhibitors Possessing Broad Spectrum Anti-Hiv-1 Activity Bioorg. Med. Chem. 2016, 24, 5988-6003 10.1016/j.bmc.2016.09.057
18. Courter, J. R.; Madani, N.; Sodroski, J.; Schon, A.; Freire, E.; Kwong, P. D.; Hendrickson, W. A.; Chaiken, I. M.; Lalonde, J. M.; Smith, A. B., III. Structure-Based Design, Synthesis and Validation of Cd4-Mimetic Small Molecule Inhibitors of Hiv-1 Entry: Conversion of a Viral Entry Agonist to an Antagonist Acc. Chem. Res. 2014, 47, 1228-1237 10.1021/ar4002735
19. Lalonde, J. M.; Elban, M. A.; Courter, J. R.; Sugawara, A.; Soeta, T.; Madani, N.; Princiotto, A. M.; Kwon, Y. D.; Kwong, P. D.; Schon, A.; Freire, E.; Sodroski, J.; Smith, A. B., III. Design, Synthesis and Biological Evaluation of Small Molecule Inhibitors of Cd4-Gp120 Binding Based on Virtual Screening Bioorg. Med. Chem. 2011, 19, 91-101 10.1016/j.bmc.2010.11.049
20. Lalonde, J. M.; Le-Khac, M.; Jones, D. M.; Courter, J. R.; Park, J.; Schon, A.; Princiotto, A. M.; Wu, X.; Mascola, J. R.; Freire, E.; Sodroski, J.; Madani, N.; Hendrickson, W. A.; Smith, A. B., III. Structure-Based Design and Synthesis of an Hiv-1 Entry Inhibitor Exploiting X-Ray and Thermodynamic Characterization ACS Med. Chem. Lett. 2013, 4, 338-343 10.1021/ml300407y
21. Melillo, B.; Liang, S.; Park, J.; Schon, A.; Courter, J. R.; Lalonde, J. M.; Wendler, D. J.; Princiotto, A. M.; Seaman, M. S.; Freire, E.; Sodroski, J.; Madani, N.; Hendrickson, W. A.; Smith, A. B., III. Small-Molecule Cd4-Mimics: Structure-Based Optimization of Hiv-1 Entry Inhibition ACS Med. Chem. Lett. 2016, 7, 330-334 10.1021/acsmedchemlett.5b00471
22. Hashimoto, C.; Narumi, T.; Otsuki, H.; Hirota, Y.; Arai, H.; Yoshimura, K.; Harada, S.; Ohashi, N.; Nomura, W.; Miura, T.; Igarashi, T.; Matsushita, S.; Tamamura, H. A Cd4Mimic as an Hiv Entry Inhibitor: Pharmacokinetics Bioorg. Med. Chem. 2013, 21, 7884-7889 10.1016/j.bmc.2013.10.005
23. Narumi, T.; Arai, H.; Yoshimura, K.; Harada, S.; Hirota, Y.; Ohashi, N.; Hashimoto, C.; Nomura, W.; Matsushita, S.; Tamamura, H. Cd4Mimics as Hiv Entry Inhibitors: Lead Optimization Studies of the Aromatic Substituents Bioorg. Med. Chem. 2013, 21, 2518-2526 10.1016/j.bmc.2013.02.041
24. Narumi, T.; Arai, H.; Yoshimura, K.; Harada, S.; Nomura, W.; Matsushita, S.; Tamamura, H. Small Molecular Cd4Mimics as Hiv Entry Inhibitors Bioorg. Med. Chem. 2011, 19, 6735-6742 10.1016/j.bmc.2011.09.045
25. van de Waterbeemd, H.; Gifford, E. Admet in Silico Modelling: Towards Prediction Paradise? Nat. Rev. Drug Discovery 2003, 2, 192-204 10.1038/nrd1032
26. Waring, M. J.; Arrowsmith, J.; Leach, A. R.; Leeson, P. D.; Mandrell, S.; Owen, R. M.; Pairaudeau, G.; Pennie, W. D.; Pickett, S. D.; Wang, J.; Wallace, O.; Weir, A. An Analysis of the Attrition of Drug Candidates from Four Major Pharmaceutical Companies Nat. Rev. Drug Discovery 2015, 14, 475-486 10.1038/nrd4609
27. Queiroz, M. J. ú.; Begouin, A.; Pereira, G.; Ferreira, P. M. T. New Synthesis of Methyl 5-Aryl or Heteroaryl Pyrrole-2-Carboxylates by a Tandem Sonogashira Coupling/5-Endo-Dig-Cyclization from ±-Iododehydroamino Acid Methyl Esters and Terminal Alkynes Tetrahedron 2008, 64, 10714-10720 10.1016/j.tet.2008.08.105
28. Li, B.; Wang, N.; Liang, Y.; Xu, S.; Wang, B. Ruthenium-Catalyzed Pyrrole Synthesis Via Oxidative Annulation of Enamides and Alkynes Org. Lett. 2013, 15, 136-139 10.1021/ol303159h
29. Balsamini, C.; Bedini, A.; Diamantini, G.; Spadoni, G.; Tontini, A.; Tarzia, G.; Di Fabio, R.; Feriani, A.; Reggiani, A.; Tedesco, G.; Valigi, R. (E)-3-(2-(N-Phenylcarbamoyl)Vinyl)Pyrrole-2-Carboxylic Acid Derivatives. A Novel Class of Glycine Site Antagonists J. Med. Chem. 1998, 41, 808-820 10.1021/jm970416w
30. Ferreira, P. M. T.; Monteiro, L. s. S.; Pereira, G. Synthesis of Substituted Oxazoles from N-Acyl-±-Hydroxyamino Acid Derivatives Eur. J. Org. Chem. 2008, 2008, 4676-4683 10.1002/ejoc.200800602
31. Weiss, H. M.; Touchette, K. M.; Angell, S.; Khan, J. The Concerted Addition of Hbr to Aryl Alkynes; Orthogonal Pi Bond Selectivity Org. Biomol. Chem. 2003, 1, 2152-2156 10.1039/b300045a
32. Devasthale, P.; Washburn, W. N.; Renduchintala, K. V.; R, S. Azolotriazinone Melanin Concentrating Hormone Receptor-1 Antagonists. WO2010/042682 A1, 2010.
33. Dhainaut, A.; Tizot, A.; Raimbaud, E.; Lockhart, B.; Lestage, P.; Goldstein, S. Synthesis, Structure, and Neuroprotective Properties of Novel Imidazolyl Nitrones J. Med. Chem. 2000, 43, 2165-2175 10.1021/jm991154w
34. Kwon, Y. D.; Lalonde, J. M.; Yang, Y.; Elban, M. A.; Sugawara, A.; Courter, J. R.; Jones, D. M.; Smith, A. B., III; Debnath, A. K.; Kwong, P. D. Crystal Structures of Hiv-1 Gp120 Envelope Glycoprotein in Complex with Nbd Analogues That Target the Cd4-Binding Site PLoS One 2014, 9, e85940 10.1371/journal.pone.0085940
35. Lalonde, J. M.; Kwon, Y. D.; Jones, D. M.; Sun, A. W.; Courter, J. R.; Soeta, T.; Kobayashi, T.; Princiotto, A. M.; Wu, X.; Schon, A.; Freire, E.; Kwong, P. D.; Mascola, J. R.; Sodroski, J.; Madani, N.; Smith, A. B., III. Structure-Based Design, Synthesis, and Characterization of Dual Hotspot Small-Molecule Hiv-1 Entry Inhibitors J. Med. Chem. 2012, 55, 4382-4396 10.1021/jm300265j
36. Acharya, P.; Lusvarghi, S.; Bewley, C. A.; Kwong, P. D. Hiv-1 Gp120 as a Therapeutic Target: Navigating a Moving Labyrinth Expert Opin. Ther. Targets 2015, 19, 765-783 10.1517/14728222.2015.1010513
37. Haim, H.; Si, Z.; Madani, N.; Wang, L.; Courter, J. R.; Princiotto, A.; Kassa, A.; DeGrace, M.; McGee-Estrada, K.; Mefford, M.; Gabuzda, D.; Smith, A. B., III; Sodroski, J. Soluble Cd4 and Cd4-Mimetic Compounds Inhibit Hiv-1 Infection by Induction of a Short-Lived Activated State PLoS Pathog. 2009, 5, e1000360 10.1371/journal.ppat.1000360
38. Madani, N.; Schon, A.; Princiotto, A. M.; Lalonde, J. M.; Courter, J. R.; Soeta, T.; Ng, D.; Wang, L.; Brower, E. T.; Xiang, S. H.; Kwon, Y. D.; Huang, C. C.; Wyatt, R.; Kwong, P. D.; Freire, E.; Smith, A. B., III; Sodroski, J. Small-Molecule Cd4Mimics Interact with a Highly Conserved Pocket on Hiv-1 Gp120 Structure 2008, 16, 1689-1701 10.1016/j.str.2008.09.005
39. Narumi, T.; Ochiai, C.; Yoshimura, K.; Harada, S.; Tanaka, T.; Nomura, W.; Arai, H.; Ozaki, T.; Ohashi, N.; Matsushita, S.; Tamamura, H. Cd4Mimics Targeting the Hiv Entry Mechanism and Their Hybrid Molecules with a Cxcr4 Antagonist Bioorg. Med. Chem. Lett. 2010, 20, 5853-5858 10.1016/j.bmcl.2010.07.106
40. Yamada, Y.; Ochiai, C.; Yoshimura, K.; Tanaka, T.; Ohashi, N.; Narumi, T.; Nomura, W.; Harada, S.; Matsushita, S.; Tamamura, H. Cd4Mimics Targeting the Mechanism of Hiv Entry Bioorg. Med. Chem. Lett. 2010, 20, 354-358 10.1016/j.bmcl.2009.10.098
41. Lin, P. F.; Blair, W.; Wang, T.; Spicer, T.; Guo, Q.; Zhou, N.; Gong, Y. F.; Wang, H. G.; Rose, R.; Yamanaka, G.; Robinson, B.; Li, C. B.; Fridell, R.; Deminie, C.; Demers, G.; Yang, Z.; Zadjura, L.; Meanwell, N.; Colonno, R. A Small Molecule Hiv-1 Inhibitor That Targets the Hiv-1 Envelope and Inhibits Cd4 Receptor Binding Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 11013-11018 10.1073/pnas.1832214100
42. Gillis, E. P.; Eastman, K. J.; Hill, M. D.; Donnelly, D. J.; Meanwell, N. A. Applications of Fluorine in Medicinal Chemistry J. Med. Chem. 2015, 58, 8315-8359 10.1021/acs.jmedchem.5b00258
43. Hagmann, W. K. The Many Roles for Fluorine in Medicinal Chemistry J. Med. Chem. 2008, 51, 4359-4369 10.1021/jm800219f
44. Park, B. K.; Kitteringham, N. R.; O’Neill, P. M. Metabolism of Fluorine-Containing Drugs Annu. Rev. Pharmacol. Toxicol. 2001, 41, 443-470 10.1146/annurev.pharmtox.41.1.443
45. Thomas, V. H.; Bhattachar, S.; Hitchingham, L.; Zocharski, P.; Naath, M.; Surendran, N.; Stoner, C. L.; El-Kattan, A. The Road Map to Oral Bioavailability: An Industrial Perspective Expert Opin. Drug Metab. Toxicol. 2006, 2, 591-608 10.1517/17425255.2.4.591
46. International Transporter, C.; Giacomini, K. M.; Huang, S. M.; Tweedie, D. J.; Benet, L. Z.; Brouwer, K. L.; Chu, X.; Dahlin, A.; Evers, R.; Fischer, V.; Hillgren, K. M.; Hoffmaster, K. A.; Ishikawa, T.; Keppler, D.; Kim, R. B.; Lee, C. A.; Niemi, M.; Polli, J. W.; Sugiyama, Y.; Swaan, P. W.; Ware, J. A.; Wright, S. H.; Yee, S. W.; Zamek-Gliszczynski, M. J.; Zhang, L. Membrane Transporters in Drug Development Nat. Rev. Drug Discovery 2010, 9, 215-236 10.1038/nrd3028
47. Smith, D. A.; Di, L.; Kerns, E. H. The Effect of Plasma Protein Binding on in Vivo Efficacy: Misconceptions in Drug Discovery Nat. Rev. Drug Discovery 2010, 9, 929-939 10.1038/nrd3287
48. Zanger, U. M.; Schwab, M. Cytochrome P450 Enzymes in Drug Metabolism: Regulation of Gene Expression, Enzyme Activities, and Impact of Genetic Variation Pharmacol. Ther. 2013, 138, 103-141 10.1016/j.pharmthera.2012.12.007
49. Tang, C.; Lin, J. H.; Lu, A. Y. Metabolism-Based Drug-Drug Interactions: What Determines Individual Variability in Cytochrome P450 Induction? Drug. Metab. Dispos. 2005, 33, 603-613 10.1124/dmd.104.003236
50. Priest, B. T.; Bell, I. M.; Garcia, M. L. Role of Herg Potassium Channel Assays in Drug Development Channels 2008, 2, 87-93 10.4161/chan.2.2.6004
51. Haertle, T.; Carrera, C. J.; Wasson, D. B.; Sowers, L. C.; Richman, D. D.; Carson, D. A. Metabolism and Anti-Human Immunodeficiency Virus-1 Activity of 2-Halo-2′,3′-Dideoxyadenosine Derivatives J. Biol. Chem. 1988, 263, 5870-5875
52. Wei, X.; Decker, J. M.; Liu, H.; Zhang, Z.; Arani, R. B.; Kilby, J. M.; Saag, M. S.; Wu, X.; Shaw, G. M.; Kappes, J. C. Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy Antimicrob. Agents Chemother. 2002, 46, 1896-1905 10.1128/AAC.46.6.1896-1905.2002
53. Chackerian, B.; Long, E. M.; Luciw, P. A.; Overbaugh, J. Human Immunodeficiency Virus Type 1 Coreceptors Participate in Postentry Stages in the Virus Replication Cycle and Function in Simian Immunodeficiency Virus Infection J. Virol. 1997, 71, 3932-3939
54. Bjorndal, A.; Deng, H.; Jansson, M.; Fiore, J. R.; Colognesi, C.; Karlsson, A.; Albert, J.; Scarlatti, G.; Littman, D. R.; Fenyo, E. M. Coreceptor Usage of Primary Human Immunodeficiency Virus Type 1 Isolates Varies According to Biological Phenotype J. Virol. 1997, 71, 7478-7487
55. Ciminale, V.; Felber, B. K.; Campbell, M.; Pavlakis, G. N. A Bioassay for Hiv-1 Based on Env-Cd4 Interaction AIDS Res. Hum. Retrov. 1990, 6, 1281-1287 10.1089/aid.1990.6.1281
56. Kolchinsky, P.; Mirzabekov, T.; Farzan, M.; Kiprilov, E.; Cayabyab, M.; Mooney, L. J.; Choe, H.; Sodroski, J. Adaptation of a Ccr5-Using, Primary Human Immunodeficiency Virus Type 1 Isolate for Cd4-Independent Replication J. Virol. 1999, 73, 8120-8126
57. Page, K. A.; Landau, N. R.; Littman, D. R. Construction and Use of a Human Immunodeficiency Virus Vector for Analysis of Virus Infectivity J. Virol. 1990, 64, 5270-5276
58. Blish, C. A.; Jalalian-Lechak, Z.; Rainwater, S.; Nguyen, M. A.; Dogan, O. C.; Overbaugh, J. Cross-Subtype Neutralization Sensitivity Despite Monoclonal Antibody Resistance among Early Subtype a, C, and D Envelope Variants of Human Immunodeficiency Virus Type 1 J. Virol. 2009, 83, 7783-7788 10.1128/JVI.00673-09
59. Long, E. M.; Rainwater, S. M.; Lavreys, L.; Mandaliya, K.; Overbaugh, J. Hiv Type 1 Variants Transmitted to Women in Kenya Require the Ccr5 Coreceptor for Entry, Regardless of the Genetic Complexity of the Infecting Virus AIDS Res. Hum. Retroviruses 2002, 18, 567-576 10.1089/088922202753747914
60. Kulkarni, S. S.; Lapedes, A.; Tang, H.; Gnanakaran, S.; Daniels, M. G.; Zhang, M.; Bhattacharya, T.; Li, M.; Polonis, V. R.; McCutchan, F. E.; Morris, L.; Ellenberger, D.; Butera, S. T.; Bollinger, R. C.; Korber, B. T.; Paranjape, R. S.; Montefiori, D. C. Highly Complex Neutralization Determinants on a Monophyletic Lineage of Newly Transmitted Subtype C Hiv-1 Env Clones from India Virology 2009, 385, 505-520 10.1016/j.virol.2008.12.032
61. Li, M.; Gao, F.; Mascola, J. R.; Stamatatos, L.; Polonis, V. R.; Koutsoukos, M.; Voss, G.; Goepfert, P.; Gilbert, P.; Greene, K. M.; Bilska, M.; Kothe, D. L.; Salazar-Gonzalez, J. F.; Wei, X.; Decker, J. M.; Hahn, B. H.; Montefiori, D. C. Human Immunodeficiency Virus Type 1 Env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies J. Virol. 2005, 79, 10108-10125 10.1128/JVI.79.16.10108-10125.2005
62. Wei, X.; Decker, J. M.; Wang, S.; Hui, H.; Kappes, J. C.; Wu, X.; Salazar-Gonzalez, J. F.; Salazar, M. G.; Kilby, J. M.; Saag, M. S.; Komarova, N. L.; Nowak, M. A.; Hahn, B. H.; Kwong, P. D.; Shaw, G. M. Antibody Neutralization and Escape by Hiv-1 Nature 2003, 422, 307-312 10.1038/nature01470
63. Keele, B. F.; Giorgi, E. E.; Salazar-Gonzalez, J. F.; Decker, J. M.; Pham, K. T.; Salazar, M. G.; Sun, C.; Grayson, T.; Wang, S.; Li, H.; Wei, X.; Jiang, C.; Kirchherr, J. L.; Gao, F.; Anderson, J. A.; Ping, L. H.; Swanstrom, R.; Tomaras, G. D.; Blattner, W. A.; Goepfert, P. A.; Kilby, J. M.; Saag, M. S.; Delwart, E. L.; Busch, M. P.; Cohen, M. S.; Montefiori, D. C.; Haynes, B. F.; Gaschen, B.; Athreya, G. S.; Lee, H. Y.; Wood, N.; Seoighe, C.; Perelson, A. S.; Bhattacharya, T.; Korber, B. T.; Hahn, B. H.; Shaw, G. M. Identification and Characterization of Transmitted and Early Founder Virus Envelopes in Primary Hiv-1 Infection Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 7552-7557 10.1073/pnas.0802203105
64. Derdeyn, C. A.; Decker, J. M.; Bibollet-Ruche, F.; Mokili, J. L.; Muldoon, M.; Denham, S. A.; Heil, M. L.; Kasolo, F.; Musonda, R.; Hahn, B. H.; Shaw, G. M.; Korber, B. T.; Allen, S.; Hunter, E. Envelope-Constrained Neutralization-Sensitive Hiv-1 after Heterosexual Transmission Science 2004, 303, 2019-2022 10.1126/science.1093137
65. Li, M.; Salazar-Gonzalez, J. F.; Derdeyn, C. A.; Morris, L.; Williamson, C.; Robinson, J. E.; Decker, J. M.; Li, Y.; Salazar, M. G.; Polonis, V. R.; Mlisana, K.; Karim, S. A.; Hong, K.; Greene, K. M.; Bilska, M.; Zhou, J.; Allen, S.; Chomba, E.; Mulenga, J.; Vwalika, C.; Gao, F.; Zhang, M.; Korber, B. T.; Hunter, E.; Hahn, B. H.; Montefiori, D. C. Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular Env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa J. Virol. 2006, 80, 11776-11790 10.1128/JVI.01730-06
66. Williamson, C.; Morris, L.; Maughan, M. F.; Ping, L. H.; Dryga, S. A.; Thomas, R.; Reap, E. A.; Cilliers, T.; van Harmelen, J.; Pascual, A.; Ramjee, G.; Gray, G.; Johnston, R.; Karim, S. A.; Swanstrom, R. Characterization and Selection of Hiv-1 Subtype C Isolates for Use in Vaccine Development AIDS Res. Hum. Retroviruses 2003, 19, 133-144 10.1089/088922203762688649
67. Wu, X.; Parast, A. B.; Richardson, B. A.; Nduati, R.; John-Stewart, G.; Mbori-Ngacha, D.; Rainwater, S. M.; Overbaugh, J. Neutralization Escape Variants of Human Immunodeficiency Virus Type 1 Are Transmitted from Mother to Infant J. Virol. 2006, 80, 835-844 10.1128/JVI.80.2.835-844.2006
68. Zhang, H.; Zhao, Q.; Bhattacharya, S.; Waheed, A. A.; Tong, X.; Hong, A.; Heck, S.; Curreli, F.; Goger, M.; Cowburn, D.; Freed, E. O.; Debnath, A. K. A Cell-Penetrating Helical Peptide as a Potential Hiv-1 Inhibitor J. Mol. Biol. 2008, 378, 565-580 10.1016/j.jmb.2008.02.066
69. Lackman-Smith, C.; Osterling, C.; Luckenbaugh, K.; Mankowski, M.; Snyder, B.; Lewis, G.; Paull, J.; Profy, A.; Ptak, R. G.; Buckheit, R. W., Jr.; Watson, K. M.; Cummins, J. E., Jr.; Sanders-Beer, B. E. Development of a Comprehensive Human Immunodeficiency Virus Type 1 Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides Antimicrob. Agents Chemother. 2008, 52, 1768-1781 10.1128/AAC.01328-07
70. McMahon, J. B.; Currens, M. J.; Gulakowski, R. J.; Buckheit, R. W., Jr.; Lackman-Smith, C.; Hallock, Y. F.; Boyd, M. R. Michellamine B, a Novel Plant Alkaloid, Inhibits Human Immunodeficiency Virus-Induced Cell Killing by at Least Two Distinct Mechanisms Antimicrob. Agents Chemother. 1995, 39, 484-488 10.1128/AAC.39.2.484
71. Kwon, Y. D.; Finzi, A.; Wu, X.; Dogo-Isonagie, C.; Lee, L. K.; Moore, L. R.; Schmidt, S. D.; Stuckey, J.; Yang, Y.; Zhou, T.; Zhu, J.; Vicic, D. A.; Debnath, A. K.; Shapiro, L.; Bewley, C. A.; Mascola, J. R.; Sodroski, J. G.; Kwong, P. D. Unliganded Hiv-1 Gp120 Core Structures Assume the Cd4-Bound Conformation with Regulation by Quaternary Interactions and Variable Loops Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 5663-5668 10.1073/pnas.1112391109
72. Otwinowski, Z.; Minor, W. Macromolecular Crystallography, Part A. In Methods Enzymol; Otwinowski, Z.; Minor, W., Eds.; Elsevier: Netherland, 1997; pp 307-326.
73. Adams, P. D.; Afonine, P. V.; Bunkoczi, G.; Chen, V. B.; Davis, I. W.; Echols, N.; Headd, J. J.; Hung, L. W.; Kapral, G. J.; Grosse-Kunstleve, R. W.; McCoy, A. J.; Moriarty, N. W.; Oeffner, R.; Read, R. J.; Richardson, D. C.; Richardson, J. S.; Terwilliger, T. C.; Zwart, P. H. Phenix: A Comprehensive Python-Based System for Macromolecular Structure Solution Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 213-221 10.1107/S0907444909052925
74. Emsley, P.; Cowtan, K. Coot: Model-Building Tools for Molecular Graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 2126-2132 10.1107/S0907444904019158